A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma (Pfizer PD)
This study is currently recruiting participants.
Verified June 2013 by University of California, San Francisco
Sponsor:
University of California, San Francisco
Collaborator:
Pfizer
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01227434
First received: October 15, 2010
Last updated: June 10, 2013
Last verified: June 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |